ð åèç
å¿
è â Lassa Fever
- ssRNA Arenaviridae
- W Africa endemic (Nigeria, Sierra Leone, Liberia, Guinea)
- Mastomys natalensis (multimammate rat) reservoir
- Transmission: rodent excreta + person-to-person + aerosol + vertical + healthcare
- 80% mild, 20% severe
- Severe: fever + facial edema + pharyngitis + bleeding + organ failure
- SNHL in 30% survivors (often permanent)
- Pregnancy 3rd trimester: 80%+ mortality
- Treatment: ribavirin (early start essential) + supportive
- Vaccines in trials (MVA-LASV, rVSV-Lassa)
å¿
è â LCMV
- House mouse reservoir
- Vertical â congenital LCMV (mimics congenital CMV: microcephaly, hydrocephalus, chorioretinitis, calcifications)
- Transplant transmission = severe multi-organ disease
- Aseptic meningitis postnatally acquired
- Treatment: supportive; ribavirin off-label for severe
å¿
è â S. American Hemorrhagic Fevers
- Junin (Argentine, Calomys musculinus) â Candid #1 vaccine effective
- Machupo (Bolivian)
- Guanarito (Venezuelan)
- Sabia (Brazilian)
- Treatment: ribavirin + supportive
å¿
è â Ribavirin for Arenaviruses
- IV regimen for Lassa
- Early start critical
- Hemolytic anemia (reversible)
- Teratogenic (avoid pregnancy except life-threatening)